Home › Asset managers › Compare 2024-2025 › Charles Schwab vs John Hancock
Charles Schwab 2024-2025 · John Hancock 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 8,674 | 7,532 | 466 | 676 | 94.2% | 91.7% |
| Board proposals | 7,415 | 6,620 | 379 | 416 | 94.6% | 92.9% |
| E&S shareholder proposals | 252 | 126 | 13 | 113 | 90.6% | 81.3% |
| Other items | 1,007 | 786 | 74 | 147 | 91.4% | 85.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
466 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | John Hancock |
|---|---|---|---|---|---|---|
| SENSUS HEALTHCARE INC. | May 27, 2025 | Election of Director: Anthony Petrelli Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SEZZLE INC. | June 10, 2025 | Election of Directors: Karen Webster Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 3 funds |
| SEZZLE INC. | June 10, 2025 | Election of Directors: Kyle Brehm Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 3 funds |
| SEZZLE INC. | June 10, 2025 | Election of Directors: Paul Paradis Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 3 funds |
| SILK ROAD MEDICAL INC. | September 5, 2024 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Silk Road to its named executive officers in connection with the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| SILVERCREST ASSET MANAGEMENT GROUP INC. | June 4, 2025 | Approval of executive compensation in an advisory, non-binding vote. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| SILVERCREST ASSET MANAGEMENT GROUP INC. | June 4, 2025 | To amend our 2012 Equity Incentive Plan, as amended, to increase the authorized number of shares issuable under the plan by 1,500,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| SITE CENTERS CORP. | May 14, 2025 | Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 5 funds |
| SKYX PLATFORMS CORP. | July 10, 2024 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 5 funds |
| SLEEP NUMBER CORP. | May 28, 2025 | Approve Amendment to the Sleep Number Corporation 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 500,000 shares Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| SMARTFINANCIAL INC. | May 22, 2025 | To approve the SmartFinancial, Inc. Omnibus Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| SOFI TECHNOLOGIES INC. | May 28, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 4 funds |
| SPRUCE POWER HOLDING CORP. | August 12, 2024 | To approve a non-binding advisory proposal on the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| SS&C TECHNOLOGIES HOLDINGS INC. | May 21, 2025 | To approve the SS&C Second Amended and Restated 2023 Stock Incentive Plan. Compensation |
Board | For | AGAINST 11 funds |
FOR 7 funds |
| STANDARD BIOTOOLS INC. | June 18, 2025 | To approve an amendment to our Amended and Restated 2011 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 17,400,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| STEELCASE INC. | July 10, 2024 | Election of Director: Catherine C. B. Schmelter Director Elections |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| STEELCASE INC. | July 10, 2024 | Election of Director: Connie K. Duckworth Director Elections |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| STEELCASE INC. | July 10, 2024 | Election of Director: Linda K. Williams Director Elections |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| STEM INC. | June 4, 2025 | To approve an amendment and restatement of the Stem, Inc. 2024 Equity Incentive Plan to increase the number of shares available for issuance by 7,500,000 shares and to extend the plan term. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| STEPSTONE GROUP INC | September 10, 2024 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025. Audit-related |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| STRATASYS LTD. | November 7, 2024 | Renewal of the Company's Compensation Policy for Executive Officers and Directors for a 3-year period, as required under the Israeli Companies Law, 5759-1999 (the "Companies Law"). Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| SUMMIT THERAPEUTICS INC. | June 12, 2025 | Approval, by a non-binding advisory vote, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 8 funds |
| SUPER GROUP (SGHC) LIMITED | June 16, 2025 | To resolve that the Company be authorised, in accordance with section 315 of the Companies Law, to make market acquisitions of the shares in the capital of the Company on the terms set out in the notice of AGM. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| SUPER MICRO COMPUTER INC. | June 4, 2025 | To approve the further amendment and restatement of the Super Micro Computer, Inc. 2020 Equity and Incentive Compensation Plan. Compensation |
Board | For | FOR 13 funds |
AGAINST 6 funds |
| SURGERY PARTNERS INC. | June 6, 2025 | Approval of the Surgery Partners, Inc. 2025 Omnibus Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 5 funds |
| SURGERY PARTNERS INC. | June 6, 2025 | Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 7 funds |
| SURMODICS INC. | August 13, 2024 | Approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| TABOOLA.COM LTD. | June 4, 2025 | Election of Class I Director: Erez Shachar Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| TABOOLA.COM LTD. | June 4, 2025 | To approve an amendment to compensation terms for our Chief Executive Officer (and Director). Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| TANGO THERAPEUTICS INC. | June 5, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| TELADOC HEALTH INC. | May 22, 2025 | Approve an amendment to the Teladoc Health, Inc. 2023 Incentive Award Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 4 funds |
| TELADOC HEALTH INC. | May 22, 2025 | Approve, on an advisory basis, the compensation of Teladoc Health's named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| TERAWULF INC. | May 5, 2025 | The approval of an amendment to the 2021 Omnibus Incentive Compensation Plan to increase the number of available shares thereunder. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| TFS FINANCIAL CORP. | February 20, 2025 | Election of Director: ASHLEY H. WILLIAMS Director Elections |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| TPG RE FINANCE TRUST INC. | May 20, 2025 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| TREDEGAR CORP. | May 8, 2025 | Non-Binding Advisory Vote to Approve Named Executive Officer Compensation Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 6 funds |
| TRIUMPH FINANCIAL INC. | April 22, 2025 | Approval of the Fourth Amendment to the Triumph Financial, Inc. 2014 Omnibus Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| TUHURA BIOSCIENCES INC. | June 23, 2025 | To approve, on a non-binding advisory basis, the compensation for our named executive officers (the Executive Compensation Proposal"). Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| ULTRA CLEAN HOLDINGS INC. | May 21, 2025 | Approval, by an advisory vote, of the compensation of Ultra Clean Holdings, Inc.'s named executive officers for fiscal 2024 as disclosed in our proxy statement for the 2025 Annual Meeting of Stockholders. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 6 funds |
| ULTRALIFE CORP. | July 16, 2024 | To approve the adoption of the Ultralife Corporation 2024 Long-Term Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| UNITED NATURAL FOODS INC. | December 17, 2024 | To approve the Fourth Amended and Restated 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| UNITED PARKS & RESORTS INC. | June 13, 2025 | Approval of the director compensation limit set forth in the United Parks & Resorts Inc. 2025 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| UNIVERSAL STAINLESS & ALLOY PRODS. INC. | January 15, 2025 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Universal's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 6 funds |
| UPSTART HOLDINGS INC. | May 23, 2025 | The approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 6 funds |
| UR-ENERGY INC. | June 5, 2025 | Amended and Restated Restricted Share Unit and Equity Incentive Plan Resolution: Ratify, confirm and approve the renewal of the Ur-Energy Inc. Amended and Restated Restricted Share Unit and Equity Incentive Plan (the "RSU&EI Plan") and approve and authorize for a period of three years all unallocated share units and shares issuable pursuant to the RSU&EI Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| UROGEN PHARMA LTD | August 6, 2024 | To approve the Company's 2024 non-employee director and officer compensation policy. Compensation |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| USANA HEALTH SCIENCES INC. | May 19, 2025 | Approval of the USANA Health Sciences, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| VALHI INC. | May 22, 2025 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| VARONIS SYSTEMS INC. | June 5, 2025 | To approve additional shares for issuance under the Amended and Restated Varonis Systems, Inc. 2023 Omnibus Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| VARONIS SYSTEMS INC. | June 5, 2025 | To approve, on a non-binding, advisory basis, the executive compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| VENTURE GLOBAL INC. | May 21, 2025 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| VERACYTE INC. | June 17, 2025 | The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| VIRGIN GALACTIC HOLDINGS INC. | June 5, 2025 | Approval of the Third Amended and Restated Virgin Galactic Holdings, Inc. 2019 Incentive Award Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| VIRIDIAN THERAPEUTICS INC. | June 20, 2025 | To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| VOYAGER THERAPEUTICS INC. | June 3, 2025 | To approve the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 5 funds |
| VUZIX CORP. | June 17, 2025 | To approve, the grant of 594,056 restricted stock units (or RSUs) to executive officers and other employees of the Company under the Company's 2023 Equity Incentive Plan, including 291,878 RSUs to Paul Travers, the Company's chief executive officer, and 118,211 RSUs to Grant Russell, the Company's chief financial officer along with the cancellation of 5,089,500 unvested stock options originally granted to those Senior Officers and others on March 17, 2021. Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| W&T OFFSHORE INC. | June 3, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement pursuant to Item 402 of Regulation S-K. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| WAVE LIFE SCIENCES LTD. | August 6, 2024 | To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement Compensation |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| WAVE LIFE SCIENCES LTD. | August 6, 2024 | To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. Capital Structure |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| WESTWOOD H | April 30, 2025 | To approve the Eleventh Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan. Compensation |
Board | Not determined | FOR 1 fund |
AGAINST 1 fund |
| WHEELS UP EXPERIENCE INC. | June 10, 2025 | To approve an amendment to the Wheels Up Experience Inc. 2021 Long-Term Incentive Plan, as amended and restated April 1, 2023 (as previously amended by Amendment No. 1 thereto, the "Amended and Restated 2021 LTIP"), to increase the aggregate number of shares of the Company's Class A common stock, $0.0001 par value per share ("Common Stock"), available for awards made under the Amended and Restated 2021 LTIP and extend the termination date of such plan to March 26, 2035. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| WHITESTONE REIT | May 15, 2025 | To approve an amendment to the 2018 Long-Term Equity Incentive Ownership Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| WM TECHNOLOGY INC. | June 24, 2025 | Non-binding advisory vote to Approve The Compensation Of Our Named Executive Officers For The Year Ended December 31, 2024. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| WRAP TECHNOLOGIES INC. | December 23, 2024 | To approve a proposed amendment to the Wrap Technologies, Inc. 2017 Equity Compensation Plan, as amended, to increase the aggregate number of shares available for the grant of awards by 7,500,000 shares, to a total of 16,500,000 shares of common stock of the Company, par value $0.0001 per share, and Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| XENIA HOTELS & RESORTS INC. | May 13, 2025 | To approve an amendment to the 2015 Incentive Award Plan to increase the number of shares that may be issued thereunder. Compensation |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| XOMA ROYALTY CORP. | May 28, 2025 | Approval of the Amended and Restated 2010 Long Term Incentive and Stock Award Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
← Previous Page 5 of 5
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.